Time to Treat First Acute Attack of Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseYoung Nam Kwon, Sung Min Kim, Tai‐Seung Nam et al.|JAMA Neurology|2024Cited by 26
TFE3-Expressing Perivascular Epithelioid Cell Tumor of the BreastHyunjin Kim, Soo Youn Cho|Journal of Pathology and Translational Medicine|2018Cited by 15
Comparison of MOG and AQP4 antibody seroprevalence in Korean adults with inflammatory demyelinating CNS diseasesJae‐Won Hyun, Ho Jin Kim, Hye Lim Lee et al.|Multiple Sclerosis Journal|2020Cited by 14
Immunosuppressive therapy in elderly patients with neuromyelitis optica spectrum disorder: a retrospective multicentre studyKi Hoon Kim, Ho Jin Kim, Yeon Hak Chung et al.|Journal of Neurology Neurosurgery & Psychiatry|2024Cited by 8
Outcomes of immunosuppressive therapy discontinuation in patients with myelin oligodendrocyte glycoprotein antibody-associated diseaseYou‐Ri Kang, Hyunjin Ju, Ki Hoon Kim et al.|Multiple Sclerosis Journal|2025Cited by 5